Navigation Links
OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma
Date:8/12/2009

CaPRI implant achieves significant drop in intraocular pressure; company advances to next generation of device, new trials

San Diego, CA (PRWEB) August 12, 2009 -- OcumatRx, an early stage company that is developing a medical device that represents a new concept for the permanent treatment of patients with Glaucoma, has announced the successful completion of clinical trials for their first device with favorable preliminary safety and tolerability. As a result, the company is now moving forward with a more sophisticated design of the device, with plans to launch new clinical trials later this year.

Dr. Bernard Press, president of OcumatRx, said that after years of research and development, the CaPRI device, named after its inventor, Dr. David Castillejos, ophthalmologist, who pioneered the pressure reduction implant (PRI) technology, showed significant results in lowering intraocular pressures during recent trials conducted in Mexico. During the trials involving 10 patients aged from 40 to 75, the first generation of the CaPRI device was inserted into one eye and the other eye was used as the control.

Press said the subjects were tested over a 12 month period and at the end of the trial the average drop in pressure was 6.4 millimeters, an achievement which is better than the current standard of care for increased intraocular pressure, which is using prescription drops.

"We are encouraged by the early results and are now finalizing the next generation of the device, designed by Dr. Castillejos after further research and development," said Press. "For glaucoma patients, having a permanent implant has the potential to stabilize pressure without the need for expensive drops, which can lose efficacy over time."

The CaPRI is inserted in a minimally invasive procedure, stabilizes intra-ocular pressure and stops the progression of Glaucoma in the ear
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Preferred Health Technology Announces Support for MGMAs Project SwipeIT
2. International Isotopes Inc. Announces Second Quarter and Six Months 2009 Financial Results
3. Fountain Healthy Aging Inc Announces $5,000,000 Equity Line Of Credit Investment Secured
4. Endo Pharmaceuticals Announces Resignation of Chief Operating Officer
5. Beckman Coulter Announces the Creation of Beckman Coulter Genomics
6. The Brain Aneurysm Foundation Announces Six Grants to Further Treatment for Brain Aneurysms
7. Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R)
8. 3SBio Inc. Announces Unaudited Second Quarter 2009 Results
9. Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results
10. Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors
11. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... 31, 2015 , ... Garden State Urology is celebrating seven ... a merger of five of the busiest urology practices in Morris County. They ... and higher quality care than they did individually. Their mission statement reflects ...
(Date:8/31/2015)... NJ (PRWEB) , ... August 31, 2015 , ... Since ... quality, patient-oriented dental care. From the moment a patient arrives at the office, ... Steven Tuckman will work with each and every patient to create a complete dental ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dr. Paul Kovatis of Orthopedic Spine & Sports ... Dr. Kovatis treats all surgical and non-surgical disorders of the leg, ankle and foot. ... system, excluding the spine. , Dr. Paul Kovatis completed his orthopedic leg, ankle and ...
(Date:8/31/2015)... ... ... Dr. Stewart Shofner of Shofner Vision Center explains what causes lazy ... eye examination can diagnose amblyopia. According to the National Eye Institute (NEI), ... to 3 out of every 100 children. , Dr. Shofner adds, “unless amblyopia ...
(Date:8/31/2015)... ... ... According to an article published August 3rd on Healio, a ... bariatric surgery “felt significantly better two years after surgery.” The article goes on to ... felt that their “mental health had been normalized” at the point when the follow-up ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3
... CPR training available to healthcare professionalsDALLAS and CLIFTON ... provider of e-Learning solutions for healthcare training and ... offer a portion of initial or renewal certification ... (BLS) online via NetLearning,s Learning Management Systems. ...
... Congress and states reconsider funding for abstinence-only programs, the ... education classes reveals that abstinence programs are plagued with ... sexuality and actively discourage the use of condoms to ... the Texas Freedom Network Education Fund - Just ...
... Teva Pharmaceuticals USA, the leading generic pharmaceutical ... of videos as part of the "Year of ... (available at www.yearofaffordablehealth.com/gallery ) is meant to ... for everyday Americans since the passage of Waxman-Hatch ...
... of MGT Capital Investments, Inc. (NYSE AMEX US: MGT), ... that focuses on products, software and equipment used by ... review of the selected products each month. A ... upcoming months is available at http://www.medicexchange.com/medicexchange-product-reviews.html . , ...
... a successful showing at the 2009,South Beach Food and ... hit over 300 stores in South Florida since the ... opened accounts include: CVS on Lincoln Road,Miami Beach; Walgreens, ... Markets, Tom Thumb, Penn Dutch, Quick Stop, Shell Gas ...
... Hematology Results Are InMUNDELEIN, Ill., Feb. 24 ... manufacturer and laboratory information systems developer today announced ... in industry for instrument reliability for its ninth ... In this annual report, Sysmex also ranked ...
Cached Medicine News:Health News:NetLearning to Offer American Heart Association e-Learning Courses 2Health News:New Texas Study Reveals Serious Flaws in Abstinence Programs 2Health News:MedicExchange Announces Launch of 'Radiology Product Review' Program 2Health News:MedicExchange Announces Launch of 'Radiology Product Review' Program 3Health News:Next Generation Waters Successfully Reaches Over 300 Stores! 2Health News:Sysmex Customer Satisfaction Ranks Highest in Independent Market Research 2
(Date:8/31/2015)... 31, 2015  The departments of Drug and Alcohol ... Gaudenzia Concept 90 to raise awareness for International Overdose ... Pennsylvania and help more Pennsylvanians ... recovery through the Building Bridges to Recovery ... every day to a disease that is fully treatable, ...
(Date:8/31/2015)... Mich. , Aug. 31, 2015  Diplomat Pharmacy, Inc. ... has announced that Phil Hagerman , Chairman & CEO, ... upcoming investor conferences. Mr. Hagerman and Mr. ... Healthcare Conference in Boston on Wednesday, ... Hagerman and Mr. Whelan are also scheduled to participate in ...
(Date:8/31/2015)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... has completed enrollment of the additional subjects, as ... this year, into the company,s Phase 2 study ... regulator (IDR) and is being evaluated as a ...
Breaking Medicine Technology:Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6
... 8, 2011 Elsevier Business Intelligence , ... conferences, is hosting Windhover,s 21 st Pharmaceutical Strategic ... in New York, NY. PSA is the only ... a diverse mix of pharma,s top talent. It,s an opportunity ...
... Medical, a leading manufacturer of integrated medical imaging display and ... year, Carrot Medical achieved significant growth in sales and an ... of 2011 with record second quarter sales, Carrot surpassed its ... company is now well positioned for the third straight year ...
Cached Medicine Technology:Biopharma Leaders Discuss Pharma's Future at Pharmaceutical Strategic Alliances in New York 2Biopharma Leaders Discuss Pharma's Future at Pharmaceutical Strategic Alliances in New York 3Carrot Medical Positioned for Third Straight Year of Triple Digit Growth 2
LUMIGAN® is a powerful eye drop medication for lowering IOP. IOP is short for intraocular pressure or eye pressure. LUMIGAN® is the first in a new class of medication....
... New REFRESH LIQUIGEL® Lubricant Eye Drops ... with the convenience of a liquid ... protection. Its extra-strength CMC formula provides ... comfort. And with the PURITE® preservative, ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
... solution is an anti-infective prescription ... may instruct you to use ... infection caused by bacteria. Bacterial ... the 2 types of eye ...
Medicine Products: